Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AstraZeneca and Bristol-Myers expand dapagliflozin collaboration to include Japan

Dec. 11, 2008

Kuvan receives marketing approval in the E.U. for hyperphenylalaninemia

Dec. 10, 2008

Amylin and Lilly provide update on FDA Byetta monotherapy submission

Dec. 10, 2008

Acrux submits Ellavie MAA in Sweden for treating menopause symptoms

Dec. 9, 2008

BioSante and Azur sign marketing agreement for Elestrin for hot flashes in menopausal women

Dec. 9, 2008

Suven's new 5-HT6 antagonist shows preclinical efficacy in obesity

Dec. 9, 2008

Recent Boehringer Ingelheim and GSK patents disclose new therapeutic agents for obesity

Dec. 5, 2008

New glucokinase activators disclosed in recent Takeda and Dainippon Sumitomo Pharma patents

Dec. 5, 2008

Trial suggests metformin chewing gum is bioequivalent to tablets

Dec. 5, 2008

Atorvastatin/fenofibrate tablet more effective than components in dyslipidemia

Dec. 4, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...